EXPLORINEER
en

US — Ars Technica

Seabirds racing home over the ocean can get jet-lagged

Policy1 min read

A new study finds that Manx shearwaters, seabirds that fly over the North Atlantic, can get jet lag. Their inner clock goes out of sync, which can throw off how they use the Sun to find their way home.

Birds Get Jet Lag Too

Jet lag is when your body thinks it is the middle of the night, but the clock says it is lunchtime. A new study in the journal Science shows that Manx shearwaters, seabirds, can get jet lag during their long trips over the ocean. Because these birds use the Sun to navigate, jet lag affects their sense of direction.

Key Facts About the Birds

  • Manx shearwaters are about the size of a pigeon.
  • They are white underneath and black on top, with very long wings.
  • They can fly hundreds of kilometers in a day over the North Atlantic.
  • They feed anywhere from a few dozen to more than 1,000 kilometers out into the Atlantic.
  • About half of their population lives in Wales. Most breed around the UK and Ireland.

How the Birds Find Home

Manx shearwaters nest in burrows on coastal islands. After feeding far out at sea, they must find their way back. Scientists think they first work out where they are, possibly by smell. Then they use the Sun as a compass. The Sun moves across the sky, so the birds must correct their direction all day. To do this, they need an inner clock that tells them the time of day. Birds, like most animals, have such a clock. But the clock in Manx shearwaters is not perfect.

Why It Matters

The study shows that even a small error in an animal's inner clock can throw off its navigation. It helps scientists understand how wild animals find their way over huge distances. It also shows that jet lag is not only a human problem.

What to Watch Next

  • Whether other migrating birds or animals also get jet lag.
  • How jet lag affects the birds' survival and their ability to get home.
  • How much the bird's clock can shift after long trips.

Glossary

Jet lag
A tired, confused feeling that happens when your body clock does not match the local time after travel across time zones.
Science
A well-known scientific journal where researchers publish their studies.

Ad

Add 150 words. Learn 10 a day.

Dicter word books send only the words you learn to your review notes.

PolicyArs Technica

The FDA wants to pull its approval of a drug. It’s not so easy.

The FDA approved Tavneos, an experimental treatment for a rare autoimmune vasculitis, in October 2021 despite doubts about its trial design, after an advisory committee narrowly voted in favor. The drug, now owned by Amgen, costs $220,000 a year and had nearly half a billion dollars in sales in fiscal 2025. In April of this year, the FDA proposed withdrawing it from the US market, citing serious liver injury and a lack of "substantial evidence" that it works.

PolicyZDNet Korea

[Op-ed] Korea's universities and public research institutes spend 19.2 trillion won on R&D but earn only 280 billion won in technology fees

According to the article, Korean universities and public research institutes spend about 19.2 trillion won a year on R&D but earned about 278 billion won in technology fees, a return of roughly 1.4%. The author argues that the government's new IP-linked R&D plan will only succeed if it avoids the past pattern of measuring results by patent filing counts, and suggests focusing on overseas patents, standard patents, and portfolio-based performance indicators.

PolicyTechCrunch

Pile-ins, payouts, and pacing pressure: the investors behind the VCs open up

Limited partners, the investors who fund venture firms, are enjoying strong conditions but are piling into the same AI leaders, OpenAI and Anthropic, often through the same venture firms. Speaking with LGT Capital Partners and TrueBridge, two LPs, the article notes that they see the concentration as a potential bonanza but also a "yellow light" risk, especially as VCs return to market faster, with some funds moving on one-year pacing instead of the usual two to two and a half years.

PolicyArs Technica

Oh captain, our captain: Ars staff remembers Patrick Stewart

Ars Technica staff mourn Sir Patrick Stewart, the award-winning actor known as Captain Jean-Luc Picard in Star Trek: The Next Generation and Professor Charles Xavier in the X-Men films, who died at 86. His family said he passed at his Los Angeles home after a brief journey with Alzheimer's Disease and Lewy Body Dementia, and asked that donations go to the Johns Hopkins Alzheimer's Disease Research Center Fund and the Alzheimer's Foundation of America Caregiver Resources. Born in Yorkshire in 1940, Stewart first caught the acting bug at 12 when he was asked to read Shylock in The Merchant of Venice.